Idlir Licaj

2.5k total citations
68 papers, 1.1k citations indexed

About

Idlir Licaj is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Idlir Licaj has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 13 papers in Physiology. Recurrent topics in Idlir Licaj's work include Cancer Risks and Factors (14 papers), Cancer-related cognitive impairment studies (12 papers) and Cancer survivorship and care (9 papers). Idlir Licaj is often cited by papers focused on Cancer Risks and Factors (14 papers), Cancer-related cognitive impairment studies (12 papers) and Cancer survivorship and care (9 papers). Idlir Licaj collaborates with scholars based in France, Norway and United States. Idlir Licaj's co-authors include Bénédicte Clarisse, Jean‐Michel Grellard, Elisabete Weiderpass, Tonje Braaten, Marie Lange, Florence Joly, Xavier Humbert, Laure Tron, Eiliv Lund and Inger Torhild Gram and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Idlir Licaj

66 papers receiving 1.1k citations

Peers

Idlir Licaj

PRM

ONCOL

PHYSI

GENET

Bénédicte Clarisse France

Alexandra M. Ward United Kingdom

Annemarie Becker‐Commissaris Netherlands

Li‐Nien Chien Taiwan

Nigel Fleeman United Kingdom

Yueh‐Hsia Chiu Taiwan

Nicola Goodson United Kingdom

Markus Bredemeier Brazil

Giorgio Reggiardo Italy

Federica Pisa Italy

Bénédicte Clarisse France

Idlir Licaj

726 ×1.5

PRM

328 ×1.1

ONCOL

119 ×0.6

PHYSI

275 ×2.2

GENET

122 ×1.0

Citations per year, relative to Idlir Licaj Idlir Licaj (= 1×) peers Bénédicte Clarisse

Countries citing papers authored by Idlir Licaj

Since Specialization

Citations

This map shows the geographic impact of Idlir Licaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idlir Licaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idlir Licaj more than expected).

Fields of papers citing papers by Idlir Licaj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idlir Licaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idlir Licaj. The network helps show where Idlir Licaj may publish in the future.

Co-authorship network of co-authors of Idlir Licaj

This figure shows the co-authorship network connecting the top 25 collaborators of Idlir Licaj. A scholar is included among the top collaborators of Idlir Licaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idlir Licaj. Idlir Licaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gitelman, Stephen E., Kimber M. Simmons, Jennifer L. Sherr, et al.. (2025). Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes. Diabetologia. 69(2). 330–342. 2 indexed citations

Licaj, Idlir, et al.. (2025). Alcohol consumption trajectories and associated factors in adult women: the Norwegian Women and Cancer study. Alcohol and Alcoholism. 60(2).

Licaj, Idlir, Sandrine Pinto, Julie Havas, et al.. (2025). Working conditions associated with return to work 2 years after breast cancer: insights from a cohort study. British Journal of Cancer. 134(1). 92–98.

Lange, Marie, et al.. (2023). COVID-19 psychological impact in general practitioners: A longitudinal study. L Encéphale. 50(2). 143–148. 4 indexed citations

Quak, Elske, Idlir Licaj, Renaud Ciappuccini, et al.. (2023). Deep Learning Denoising Improves and Homogenizes Patient [18F]FDG PET Image Quality in Digital PET/CT. Diagnostics. 13(9). 1626–1626. 3 indexed citations

Licaj, Idlir, Elodie Coquan, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2023). Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer. 129(7). 1085–1095. 4 indexed citations

Singh, Dave, Gerard J. Criner, Àlvar Agustí, et al.. (2023). Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis. International Journal of COPD. Volume 18. 1595–1599. 17 indexed citations

Dugué, J., et al.. (2021). Head and neck cancer survivors’ pain in France: the VICAN study. Journal of Cancer Survivorship. 16(1). 119–131. 15 indexed citations

Coquan, Elodie, Pierre-Emmanuel Brachet, Idlir Licaj, et al.. (2021). CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure. BMC Cancer. 21(1). 1054–1054. 3 indexed citations

10.

Jégoux, F., et al.. (2021). Social and sexual health of thyroid cancer survivors 2 and 5 years after diagnosis: the VICAN survey. Supportive Care in Cancer. 30(3). 2777–2785. 1 indexed citations

11.

Ciappuccini, Renaud, Idlir Licaj, E. Babin, et al.. (2020). ¹⁸ F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study. Thyroid. 31(5). 800–809. 15 indexed citations

12.

Silva, Angélique Da, Christelle Lévy, Djelila Allouache, et al.. (2020). Efficacy and Safety of Weekly Paclitaxel in Breast Cancer With Symptomatic Bone Marrow Infiltration. Anticancer Research. 40(5). 2955–2960. 1 indexed citations

13.

Joly, Florence, et al.. (2020). Cancer-related fatigue among long-term survivors of breast, cervical, and colorectal cancer: a French registry–based controlled study. Supportive Care in Cancer. 28(12). 5839–5849. 25 indexed citations

14.

Licaj, Idlir, B. Géry, R. Gervais, et al.. (2019). Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation. European Annals of Otorhinolaryngology Head and Neck Diseases. 136(4). 257–261. 6 indexed citations

15.

Santos, Mélanie Dos, Marie Lange, R. Gervais, et al.. (2019). Impact of anxio-depressive symptoms and cognitive function on oral anticancer therapies adherence. Supportive Care in Cancer. 27(9). 3573–3581. 15 indexed citations

16.

Weiderpass, Elisabete, et al.. (2018). Factors Associated with High Weight Gain and Obesity Duration: The Norwegian Women and Cancer (NOWAC) Study. Obesity Facts. 11(5). 381–392. 8 indexed citations

17.

Lasnon, Charline, Idlir Licaj, Pascal Dô, et al.. (2018). Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46(2). 421–428. 28 indexed citations

18.

Licaj, Idlir, Sven Sandin, Guri Skeie, et al.. (2016). Alcohol consumption over time and mortality in the Swedish Women’s Lifestyle and Health cohort. BMJ Open. 6(11). e012862–e012862. 14 indexed citations

19.

Carayol, Marion, Idlir Licaj, David Achaintre, et al.. (2015). Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC. PLoS ONE. 10(8). e0135437–e0135437. 86 indexed citations

20.

Licaj, Idlir, Mohamed Mouloud Haddak, Martine Hours, & Mireille Chiron. (2011). Deprived neighborhoods and risk of road trauma (incidence and severity) among under 25year-olds in the Rhône Département (France). Journal of Safety Research. 42(3). 171–176. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact